4//SEC Filing
Amoroso Michael 4
Accession 0000950170-24-121726
CIK 0001357874other
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 7:14 PM ET
Size
8.9 KB
Accession
0000950170-24-121726
Insider Transaction Report
Form 4
Amoroso Michael
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2024-11-04$8.19/sh−3,012$24,668→ 28,537 total - Exercise/Conversion
Common Stock
2024-11-02+9,443→ 31,549 total - Exercise/Conversion
Restricted Stock Units
2024-11-02−9,443→ 9,444 total→ Common Stock (9,443 underlying)
Footnotes (4)
- [F1]Represents the vesting of Restricted Stock Units ("RSUs") on November 2, 2024.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F4]On November 2, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on November 2, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Documents
Issuer
PRECISION BIOSCIENCES INC
CIK 0001357874
Entity typeother
Related Parties
1- filerCIK 0001830874
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 7:14 PM ET
- Size
- 8.9 KB